Open AccessTEM-MM-101: A Phase I/IIa Dose Escalation Study Evaluating the Safety and Activity of Autologous CD34+ Enriched Hematopoietic Progenitor Cells Genetically Modified for Human Interferon-α2 in Multiple Myeloma Patients with Early Relapse after Intensive Front Line Therapy
Author(s) -
Bernhard Gentner,
Francesca Farina,
Matteo Giovanni Carrabba,
Magda Marcatti,
Stefania Girlanda,
Gabriele Antonarelli,
Alessia Capotondo,
Stefania Mazzoleni,
Carlo Russo,
Luigi Naldini,
Fabio Ciceri
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2019-123749
Subject(s) - multiple myeloma , progenitor cell , medicine , immunology , cancer research , cd34 , transplantation , haematopoiesis , stem cell , genetic enhancement , biology , biochemistry , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom